Financial Services

Promising new 96-week data shows Vir's therapy could redefine care for severe hepatitis delta, as its oncology pipeline and financial runway also advance.

Erasca reports promising early data for its pan-RAS inhibitor, ERAS-0015, showing tumor shrinkage at low doses and shaking up the competitive landscape.

Digi International's new turnkey solution lets MSPs offer enterprise-grade 5G connectivity and recurring revenue without the upfront cost or complexity.

Interim data suggests LX2020 is well-tolerated and may reduce dangerous arrhythmias by targeting the root cause of PKP2-associated cardiomyopathy.

A new White House executive order and a proposed $1.5T budget are shaking up defense contracting. Here's how agile firms like Volatus are set to win.

Backed by Purolator, a massive network expansion by Williams Pharmalogistics aims to reshape Canada's temperature-controlled medical delivery landscape.

The plant-based food supplier raised its revenue and profit forecast after a strong year-end recovery, sparking investor confidence and signaling operational agility.

With its new thalassemia drug AQVESME launching, Agios aims for blockbuster status while navigating a key safety warning and advancing a broad pipeline.

With FDA alignment for its rapid postpartum depression therapy and new trials for anxiety, Reunion Neuroscience is pioneering a new era of mental health.

With key partners secured, Delfin Midstream is set to greenlight America's pioneering floating LNG project, reshaping the global energy map.

KEY Investment Partners acquires BellRock Brands' portfolio out of receivership, launching MM Brands with Joe Bayern to lead a wellness-focused revival.

With pivotal cancer drug data looming and a new nuclear supply chain, Bicycle Therapeutics is betting big on its novel platform. Will 2026 be its breakout year?

Kipling Group appoints real estate veteran Michael Case as President & COO, signaling a strategic push for growth in Canada's evolving property market.

The burger chain posted positive sales and aggressive 2026 growth plans, navigating weather woes and inflation with new menu items and operational tweaks.

As hockey costs soar, a corporate program backed by legends like Wickenheiser passes a major milestone, helping more Canadian kids get on the ice.

Cytek Biosciences reports preliminary 2025 revenue of $201M, beating estimates with a major Q4 growth surge ahead of its key J.P. Morgan presentation.

West Red Lake Gold officially begins commercial production at its historic Madsen Mine, signaling a new era of gold output in the prolific Red Lake district.

The food services giant is the only company in its sector to earn CDP's top climate rating, signaling a major shift in industry sustainability standards.

Dolf van den Brink will step down in 2026 after a turbulent tenure, leaving an ambitious new strategy for his successor to execute amid market skepticism.

A new study reveals a crisis in the compact tractor industry, with 47% of online customer inquiries going completely unanswered, costing dealers millions.